These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25646711)

  • 1. Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.
    Lim SV; Marenzana M; Hopkinson M; List EO; Kopchick JJ; Pereira M; Javaheri B; Roux JP; Chavassieux P; Korbonits M; Chenu C
    Endocrinology; 2015 Apr; 156(4):1362-71. PubMed ID: 25646711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifelong Excess in GH Elicits Sexually Dimorphic Effects on Skeletal Morphology and Bone Mechanical Properties.
    Dixit M; Louis LD; Basta-Pljakic J; Yildirim G; Poudel SB; Kumararaja F; List EO; Duran SO; Kopchick JJ; Ruff RR; Schaffler MB; Yakar S
    J Bone Miner Res; 2022 Nov; 37(11):2201-2214. PubMed ID: 36069368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender.
    Eckstein F; Lochmüller EM; Koller B; Wehr U; Weusten A; Rambeck W; Hoeflich A; Wolf E
    Growth Horm IGF Res; 2002 Apr; 12(2):116-25. PubMed ID: 12175649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal in vivo effects of growth hormone overexpression on bone in transgenic mice.
    Eckstein F; Weusten A; Schmidt C; Wehr U; Wanke R; Rambeck W; Wolf E; Mohan S
    J Bone Miner Res; 2004 May; 19(5):802-10. PubMed ID: 15068504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of growth hormone in selectively protein-deprived rats decreases BMD and bone strength.
    Ammann P; Brennan TC; Mekraldi S; Aubert ML; Rizzoli R
    Bone; 2010 Jun; 46(6):1574-81. PubMed ID: 20178866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.
    Nordstrom SM; Carleton SM; Carson WL; Eren M; Phillips CL; Vaughan DE
    Bone; 2007 Dec; 41(6):995-1004. PubMed ID: 17888748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites.
    Sotelo AI; Bartke A; Turyn D
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):446-52. PubMed ID: 8279226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
    J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender specific LRP5 influences on trabecular bone structure and strength.
    Dubrow SA; Hruby PM; Akhter MP
    J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary morphology of transgenic mice expressing bovine growth hormone.
    Stefaneanu L; Kovacs K; Bartke A; Mayerhofer A; Wagner TE
    Lab Invest; 1993 May; 68(5):584-91. PubMed ID: 8388524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cerebral overexpression of growth hormone alters cardiac function, morphology, energy metabolism and catecholamines in transgenic mice.
    Bohlooly-Y M; Bollano E; Mobini R; Soussi B; Tornell J; Omerovic E
    Growth Horm IGF Res; 2005 Apr; 15(2):148-55. PubMed ID: 15809019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes.
    Naar EM; Bartke A; Majumdar SS; Buonomo FC; Yun JS; Wagner TE
    Biol Reprod; 1991 Jul; 45(1):178-87. PubMed ID: 1878431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of growth hormone treatment affects trabecular bone microarchitecture and mineralization in growth hormone deficient mice.
    Kristensen E; Hallgrímsson B; Morck DW; Boyd SK
    Bone; 2010 Aug; 47(2):295-300. PubMed ID: 20399917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.
    Chen NY; Chen WY; Bellush L; Yang CW; Striker LJ; Striker GE; Kopchick JJ
    Endocrinology; 1995 Feb; 136(2):660-7. PubMed ID: 7835300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune function in transgenic mice overexpressing growth hormone (GH) releasing hormone, GH or GH antagonist.
    Dialynas E; Brown-Borg H; Bartke A
    Proc Soc Exp Biol Med; 1999 Jul; 221(3):178-83. PubMed ID: 10404033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal changes in transgenic male mice expressing human cytochrome p450 aromatase.
    Peng Z; Li X; Mäkelä S; Väänänen HK; Poutanen M
    J Bone Miner Res; 2004 Aug; 19(8):1320-8. PubMed ID: 15231020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effect of human, but not bovine, growth hormone expression on numbers of tuberoinfundibular dopaminergic neurons in transgenic mice.
    Phelps CJ; Bartke A
    Endocrinology; 1997 Jul; 138(7):2849-55. PubMed ID: 9202227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice.
    Glatt V; Canalis E; Stadmeyer L; Bouxsein ML
    J Bone Miner Res; 2007 Aug; 22(8):1197-207. PubMed ID: 17488199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-destructive technique for 3-D microstructural phenotypic characterisation of bones in genetically altered mice: preliminary data in growth hormone transgenic animals and normal controls.
    Graichen H; Lochmüller EM; Wolf E; Langkabel B; Stammberger T; Haubner M; Renner-Müller I; Englmeier KH; Eckstein F
    Anat Embryol (Berl); 1999 Mar; 199(3):239-48. PubMed ID: 10068090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.